Eli Lilly's experimental drug, retatrutide, showed strong results in a late-stage trial, helping patients lose nearly 29% of their body weight while reducing osteoarthritis pain.
Cracker Barrel CEO Julie Masino admitted the company's turnaround is taking longer than expected after summer controversy hurt consumer trust and recovery efforts.
PepsiCo will cut hundreds of products after Elliott Investment Management pushes for cost reductions. The company will reduce SKUs by 20% to boost value.
AutoZone plans an aggressive store expansion with 53 new locations opened globally in the latest quarter, bringing total to 7,710 stores as auto parts retailer grows.
Beef prices may drop but consumers face "slow and painful" wait for relief, warns a Wells Fargo economist. Cattle shortages continue to keep costs high.
Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand for high-protein foods and fitness gear.